Rights and permissions
About this article
Cite this article
Azithromycin: cost advantage over standard penicillins for treating CAP. Inpharma Wkly. 1330, 5–6 (2002). https://doi.org/10.2165/00128413-200213300-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200213300-00010